دورية أكاديمية

Use of Intracameral Tissue Plasminogen Activator During Uveitic Cataract Surgery.

التفاصيل البيبلوغرافية
العنوان: Use of Intracameral Tissue Plasminogen Activator During Uveitic Cataract Surgery.
المؤلفون: Hu WF; Flaum Eye Institute, University of Rochester, Rochester, New York, USA., Etheridge T; Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah, Salt Lake City, Utah, USA., Larochelle MB; Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah, Salt Lake City, Utah, USA.
المصدر: Ocular immunology and inflammation [Ocul Immunol Inflamm] 2024 Jul; Vol. 32 (5), pp. 673-677. Date of Electronic Publication: 2023 Apr 20.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 9312169 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-5078 (Electronic) Linking ISSN: 09273948 NLM ISO Abbreviation: Ocul Immunol Inflamm Subsets: MEDLINE
أسماء مطبوعة: Publication: London : Informa Healthcare
Original Publication: Buren, The Netherlands : Aeolus Press, c1993-
مواضيع طبية MeSH: Tissue Plasminogen Activator*/administration & dosage , Tissue Plasminogen Activator*/therapeutic use , Visual Acuity*/physiology , Fibrinolytic Agents*/therapeutic use , Fibrinolytic Agents*/administration & dosage , Uveitis*/drug therapy, Humans ; Male ; Retrospective Studies ; Female ; Middle Aged ; Aged ; Adult ; Anterior Chamber/drug effects ; Cataract Extraction ; Aged, 80 and over
مستخلص: Purpose: To report the outcomes of intracameral tissue plasminogen activator (tPA) use during uveitic cataract surgery.
Design: Retrospective case series from a single United States tertiary center of 36 eyes from 31 consecutive patients with established uveitis who received intraoperative intracameral tPA during cataract surgery between 2016 and 2020.
Results: Mean visual acuity (VA) improved from logMAR 1.0 ± 0.7 preoperatively to logMAR 0.7 ± 0.8 by POM12. VA improved from baseline postoperatively (POM1 p  = 0.0002, POM6 p  = 0.006 and POM12 p  = 0.007). Minimal to no anterior chamber inflammation was achieved in 47.2% of the eyes by POW1 and 80.0% of the eyes by POM1. Mean clock-hours of posterior synechiae improved from 8.2 ± 3.8 preoperatively to 0.1 ± 0.6 by POM12. Six eyes developed hyphema and/or vitreous hemorrhage, four of which resolved spontaneously.
Conclusions: Adjunctive intracameral tPA during uveitic cataract surgery improves VA and intraocular inflammation, but risks postoperative hemorrhage. Intraoperative tPA as adjunctive anti-inflammatory therapy warrants randomized prospective studies.
References: J Cataract Refract Surg. 1991 Sep;17(5):543-6. (PMID: 1941585)
Am J Ophthalmol. 1988 Dec 15;106(6):719-22. (PMID: 3143267)
Exp Eye Res. 1987 Jan;44(1):55-63. (PMID: 3104075)
BMC Ophthalmol. 2020 Mar 17;20(1):109. (PMID: 32183739)
Retin Cases Brief Rep. 2012 Summer;6(3):290-3. (PMID: 25389735)
Ophthalmology. 1990 Feb;97(2):184-9. (PMID: 2109297)
Int J Ophthalmol. 2021 May 18;14(5):676-683. (PMID: 34012881)
Ophthalmologe. 1999 Sep;96(9):587-93. (PMID: 10501987)
Br J Ophthalmol. 1998 Jul;82(7):810-5. (PMID: 9924378)
Br J Ophthalmol. 2005 Nov;89(11):1458-61. (PMID: 16234453)
Br J Ophthalmol. 2000 Sep;84(9):983-6. (PMID: 10966949)
Br J Ophthalmol. 2014 Feb;98(2):252-5. (PMID: 24276695)
J Cataract Refract Surg. 1997 Jul-Aug;23(6):873-7. (PMID: 9292671)
Am J Ophthalmol. 2014 Oct;158(4):676-692.e7. (PMID: 24983790)
Int Ophthalmol. 1994-1995;18(5):277-80. (PMID: 7607808)
معلومات مُعتمدة: UL1 TR002538 United States TR NCATS NIH HHS; UM1 TR004409 United States TR NCATS NIH HHS
فهرسة مساهمة: Keywords: Cataract surgery; intraocular inflammation; postoperative inflammation; tissue plasminogen activator; uveitis
المشرفين على المادة: EC 3.4.21.68 (Tissue Plasminogen Activator)
0 (Fibrinolytic Agents)
تواريخ الأحداث: Date Created: 20230420 Date Completed: 20240701 Latest Revision: 20240703
رمز التحديث: 20240703
مُعرف محوري في PubMed: PMC10587359
DOI: 10.1080/09273948.2023.2194410
PMID: 37079881
قاعدة البيانات: MEDLINE
الوصف
تدمد:1744-5078
DOI:10.1080/09273948.2023.2194410